Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 358,522 | 143,678 | 942,261 | 705,788 | 444,635 |
| Depreciation Amortization | 950,834 | 469,950 | 1,936,899 | 1,353,365 | 895,745 |
| Income taxes - deferred | -63,827 | -24,015 | -43,694 | -60,513 | -67,194 |
| Accounts receivable | -30,559 | -383,041 | -49,184 | -43,231 | -24,356 |
| Accounts payable and accrued liabilities | -19,029 | -27,075 | -9,194 | -52,646 | -30,055 |
| Other Working Capital | 120,755 | -362,459 | -134,931 | -185,499 | -276,322 |
| Other Operating Activity | -62,761 | 336,282 | -358,606 | -138,256 | 26,087 |
| Operating Cash Flow | $1,253,937 | $153,319 | $2,283,551 | $1,579,008 | $968,539 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -322,581 | -150,805 | -724,648 | -489,297 | -350,274 |
| Net Acquisitions | 12,063 | 8,665 | 1,083 | 16,677 | -22,289 |
| Purchase Of Investment | -68,120 | -49,254 | -111,303 | -92,794 | -91,316 |
| Sale Of Investment | 55,200 | 16,133 | 60,762 | 51,964 | 28,633 |
| Investing Cash Flow | $-323,437 | $-175,262 | $-774,106 | $-513,450 | $-435,245 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 807,079 | 111,151 | 755,530 | 665,502 | 683,295 |
| Debt Issued | 10,374 | 6,947 | 1,039,821 | 1,034,077 | 264,286 |
| Debt Repayment | -26,603 | -15,235 | -784,532 | -766,978 | -762,347 |
| Common Stock Issued | N/A | N/A | 21,233 | 20,296 | 21,438 |
| Dividend Paid | -528,434 | -89,596 | -740,652 | -618,042 | -568,884 |
| Other Financing Activity | -1,026,291 | -11,105 | -1,995,452 | -1,843,082 | -696,573 |
| Financing Cash Flow | $-763,874 | $2,162 | $-1,704,051 | $-1,508,226 | $-1,058,785 |
| Exchange Rate Effect | -71,204 | -33,779 | -24,404 | 71,915 | 39,170 |
| Beginning Cash Position | 1,388,937 | 1,367,283 | 1,561,072 | 1,492,323 | 1,576,777 |
| End Cash Position | 1,484,359 | 1,313,724 | 1,342,062 | 1,121,570 | 1,090,456 |
| Net Cash Flow | $95,422 | $-53,559 | $-219,010 | $-370,753 | $-486,321 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,253,937 | 153,319 | 2,283,551 | 1,579,008 | 968,539 |
| Capital Expenditure | -324,435 | -152,563 | -762,794 | -498,165 | -355,727 |
| Free Cash Flow | 929,502 | 756 | 1,520,757 | 1,080,843 | 612,812 |